Related Experiment Videos
Carcinoids associated with multiple endocrine neoplasia syndromes
American Journal of Surgery
|July 1, 1987
Summary
Carcinoid tumors are linked to Multiple Endocrine Neoplasia (MEN) types 1 and 2, often originating from the foregut. MEN should be suspected in patients with foregut carcinoids, guiding clinical management.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Carcinoid tumors can be associated with Multiple Endocrine Neoplasia (MEN) types 1 and 2.
- Understanding the specific relationships between carcinoids and MEN subtypes is crucial for diagnosis and management.
Purpose of the Study:
- To investigate the clinical relationships between carcinoid tumors and MEN types 1 and 2.
- To identify the origins and characteristics of carcinoids in patients with MEN.
Main Methods:
- Review of nine patients with carcinoids and other endocrine tumors.
- Analysis of these nine patients combined with 56 previously reported cases from the literature.
Main Results:
- Most MEN-associated carcinoids (69%) originate from the foregut (thymus, bronchus, stomach, duodenum), unlike typical midgut/hindgut origins.
- Carcinoids are more frequently associated with MEN type 1 (59 patients) than MEN type 2 (6 patients).
- Thymic carcinoids in MEN are more common in males and often malignant (82%), while bronchial carcinoids are more common in females and typically benign (74%).
- Strong associations exist between thymic carcinoids and parathyroid tumors, and bronchial carcinoids and pituitary tumors.
- Hyperparathyroidism in carcinoid patients often involves parathyroid hyperplasia or multiple adenomas (82%).
Conclusions:
- Carcinoids can occur in association with both MEN type I and MEN type II.
- Foregut carcinoids warrant suspicion for underlying MEN.
- Clinical presentation of ectopic ACTH production in MEN patients can suggest bronchial carcinoids in females and thymic carcinoids in males.
- Routine thymectomy in MEN type I patients is recommended due to potential ectopic parathyroid glands and carcinoid development risk.